Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
about
MicroRNA: Implications for Alzheimer Disease and other Human CNS DisordersCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative DiseasesOxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Human cerebral neuropathology of Type 2 diabetes mellitusRole of vascular risk factors and vascular dysfunction in Alzheimer's disease.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's diseaseReactive oxygen species in the regulation of synaptic plasticity and memory.Neurovascular function in Alzheimer's disease patients and experimental models.Hypertension and cognitive functionPMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β-Induced Cognitive Deficits through Modulation of Neuroinflammation.Neurovascular and neurometabolic derailment in aging and Alzheimer's disease.Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative StressRedox processes in neurodegenerative disease involving reactive oxygen speciesCerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibitionCerebral amyloid angiopathy: progressive disruption of the neurovascular unit.Photobiomodulation with near infrared light mitigates Alzheimer's disease-related pathology in cerebral cortex - evidence from two transgenic mouse modelsVascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.Nitric oxide signaling in brain function, dysfunction, and dementia.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Plant polyphenols in the treatment of age-associated diseases: revealing the pleiotropic effects of icariin by network analysis.Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model.Effects of exercise on capillaries in the white matter of transgenic AD mice.Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice.Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats.[Vascular factors in the pathogenesis of Alzheimer's disease].A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease.
P2860
Q24652987-30949DDF-4AA9-4FCF-A65C-F310C1555977Q26751153-B3227B0E-4BED-4A3D-AA1B-D43A2181B7C7Q26772733-7747CAD7-5DC9-4446-9F55-C3A1D1B12BE4Q33707944-021EBF7F-D1A7-4B54-A95F-DBDB052C77A8Q33710643-F2731C13-EF6A-40BB-A252-FFC17D83765CQ34055011-6C953AD6-8EAC-4C18-B803-C1CC1C5F1B56Q34193337-079EBB82-42E4-4744-90FD-C4C44B62459EQ34268223-C9C1E627-693C-4219-AB57-FDC057361468Q34358146-7917A5E2-4DAE-4DC2-BF46-0C1DEA85807BQ34805998-B85ABF27-AA03-4D22-8E70-36233D37612EQ35088223-3333D70D-07C4-4705-8AE5-08FAA1EE5613Q35178724-4A17A12B-E703-4F48-AA1B-0482D6C1FC25Q35511034-7BBAD92C-3859-4BCB-885A-8C7D639C7051Q35651255-F404AC7B-51CC-4CC3-84BE-603D7583197CQ35858581-41E0658F-F5A6-48D5-8F8F-0C9D53DED744Q36460613-0E2A3160-C1DF-4FA7-814D-E36EB2F323D8Q37061721-0C4EB2D3-E76A-40AB-8E6D-0770AE02BB7AQ37186592-8D1E9747-FAEC-4C71-AEB1-FC309E7B6C57Q37690709-9AD3C7DD-8E37-4859-8523-B08373DF4294Q37725077-C6128A39-9CB7-469D-B725-75C6930078B4Q37785420-0540ACC9-2556-45E3-B718-333E293C02F6Q38094984-BA24AFA6-7440-4BE8-8507-F88CDDD8BA00Q38169127-C9E6CB9E-B26A-4799-9404-A0E997A13637Q38305111-2CCB30EC-F526-4679-99B9-BEF3C88AB0B9Q38781022-245605B5-F28E-4533-AFEA-288F99FF758BQ41442551-A2FD45B7-F2AF-4F69-8F58-FB975BF4E187Q42371591-743D17D7-4D72-4CB0-876C-670281C35EABQ42968483-8EC460D0-42D9-4839-B3C2-13447CCAF607Q45896609-F416241C-F7BE-4047-8C82-A2AFA7AA19E5Q45955749-F92DAE30-BBF0-4F03-9E68-6D6EE70CAE5CQ47872250-022886C0-7DC9-4665-B904-60068604EA3CQ55514851-FADDA9AF-117C-4306-8565-91433601A754
P2860
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
@en
type
label
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
@en
prefLabel
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
@en
P2093
P2860
P1476
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
@en
P2093
P2860
P304
P356
10.1113/EXPPHYSIOL.2007.038729
P577
2007-10-02T00:00:00Z